Page 59 - Acrobat J Trad-21-3-2566

542 วารสารการแพทย์แผนไทยและการแพทย์ ทางเลือก ปีที่ 21 ฉบับที่ 3 กันยายน-ธันวาคม 2566

of Favipiravir – A potential treatment in the COVID-19 of Andrographis paniculata extract in patients with mild
pandemic?. J Virus Erad. 2020;6:45-51. COVID-19: A randomized controlled trial. Arch Intern
5. Yaylaci S, Dheir H, Şenocak D, Genc AB, Kocayigit H, Med Res. 2022;5(3):423-7.
Çekiç D, Varım C, Aydın A, Koroglu M, Karabay O. 12. Suwankesawong W, Saokaew S, Permsuwan U, Chai-
The effects of favipiravir on hematological parameters of yakunapruk N. Characterization of hypersensitivity reac-
covıd-19 patients. Rev Assoc Med Bras. 2020;66(Suppl tions reported among Andrographis paniculata users in
2):65-70. Thailand using Health Product Vigilance Center (HPVC)
6. Takoi H, Togashi Y, Fujimori D, Kaizuka H, Otsuki S, database. BMC Complement Altern Med. 2014;14:515.
Wada T, Takeuchi Y, Abe S. Favipiravir-induced fever 13. Leelarasamee A, Suankratay C, Hunnangkul S, Udom-
in coronavirus disease 2019: A report of two cases. Int punturak S, Krittayaphong R, Poonsrisawat J, Wongsa-
J Infect Dis. 2020;101:188-90. korn N, Ittipanitphong C, Sirimai S, Prakairoongthong
7. Shi TH, Huang YL, Chen CC, Pi WC, Hsu YL, Lo LC, Chen P, Rattanamaneekorn S, Chaicharoenpong K. The
WY, Fu SL, Lin CH. Andrographolide and its fluorescent efficacy and safety of Andrographis paniculata extract
derivative inhibit the main proteases of 2019-nCoV and for the treatment of acute nonspecific upper respiratory
SARS-CoV through covalent linkage. Biochem Biophys tract infections: A randomized double blind placebo
Res Commun. 2020;533(3):467–73. controlled trial. J Med Assoc Thai. 2021;104(7):1204-13.
8. Benjaponpithak A, Visithanon K, Sawaengtham T, 14. Rattanaraksa D, Khempetch R, Poolwiwatchaikool U,
Thaneerat T, Wanaratna K. Short communication on Nimitvilai S, Loatrakul O, Srimanee P. The efficacy and
use of andrographis herb (FA THALAI CHON) for the safety of Andrographis paniculata extract for treat-
treatment of COVID-19 patients. J Thai Trad Alt Med. ment of COVID-19 patients with mild symptoms,
2021:19(1);229-33. (in Thai) Nakhonpathom Hospital. Region 4-5 Medical Journal.
9. Sa-ngiamsuntorn K, Suksatu A, Pewkliang Y, Thongsri 2021;40(2):269-82. (in Thai)
P, Kanjanasirirat P, Manopwisedjaroen S, Charoensut- 15. Worakunphanich W, Thavorncharoensap M, Youngkong
thivarakul S, Wongtrakoongate P, Pitiporn S, Chaopre- S, Thadanipon K, Thakkinstian A. Safety of Androgra-
echa J, Kongsomros S, Jearawuttanakul K, Wannalo phis paniculata: a systematic review and meta-analysis.
W, Khemawoot P, Chutipongtanate S, Borwornpinyo Pharmacoepidemiol Drug Saf. 2021;30:727–39.
S, Thitithanyanont A, Hongeng S. Anti-SARS-CoV-2 16. Kaewdech A, Nawalerspanya S, Assawasuwannakit
Activity of Andrographis paniculata extract and its major S, Chamroonkul N, Jandee S, Sripongpun P. The use
component andrographolide in human lung epithelial of Andrographis paniculata and its effects on liver
cells and cytotoxicity evaluation in major organ cell biochemistry of patients with gastrointestinal problems
representatives. J Nat Prod. 2021;84(4):1261–70. in Thailand during the COVID-19 pandemic: a cross
10. Prempree P, Mungaomklang A, Tangkiatkumjai M, sectional study. Scientific Reports. 2022;12(1):18213.
Phodha T, Kwankhao P, Chewchuapun K, Charuenporn 17. Tanwettiyanont J, Piriyachananusorn N, Sangsoi L,
C, Monta D, Karapakdee T. SARS-CoV-2 clearance from Boonsong B, Sunpapoa C, Tanamatayarat P, Na-Ek N,
Andrographis paniculata, Boesenbergia rotunda, and Kanchanasurakit S. Use of Andrographis paniculata
favipiravir among mild COVID-19 cases in Klong Prem (Burm. f.) Wall. Ex Nees and risk of pneumonia in hos-
Central Prison during mid-2021: a retrospective study. pitalised patients with mild coronavirus disease 2019:
OSIR. 2022;15(4):131-7. a retrospective cohort study. Front Med (Lausanne).
11. Wanaratna K, Leethong P, Inchai N, Chueawiang W, 2022:9:947373.
Sriraksa P, Tabmee A, Sirinavin S. Efficacy and safety